FORT LAUDERDALE, Fla., May 30, 2012 (GLOBE NEWSWIRE) -- BIOflex Medical Magnetics, Inc. ("BMMI") announced today that it intends to launch its unique Comfort Sleep System Mattress Overlay following the completion of the acquisition by iTech Medical, Inc. (OTC:IMSU) (FWB:0IM), announced May 23, 2012. The BIOflex Comfort Sleep System incorporates the Company's patented concentric circle magnets, strategically imbedded in the upper layer to improve circulation, accelerate healing and enhance pain relief.
According to the Centers for Disease Control (CDC), insufficient sleep is a public health epidemic with sleep insufficiency linked to motor vehicle crashes, industrial disasters, and medical and other occupational errors. An estimated 50-70 million U.S. adults have a sleeping disorder, many resulting from chronic back pain.
"We're very excited about the launch of our Comfort Sleep System Mattress Overlay," said Charles Zablotsky, CEO of BIOflex Medical Magnetics. "Our unique mattress overlay is designed to reduce chronic back pain. The new patented magnetic mattress toppers will be using 100% gel-infused foam to help maintain the body's temperature for a deeper sleep. Gel memory foam is designed to absorb and distribute pressure and is viewed as the most exciting product in sleep today. With the infusion of gel, we now provide a unique and superior product that offers a cool sleep with luxurious comfort, durability, and pressure relief."
BIOflex Medical Magnetics is a pioneer in the practice of medical magnetic therapy with its 25 years of market leadership. The BIOflex magnetic technology is founded on academic and clinical research demonstrating its ability to support the body's natural healing processes. BIOflex Medical Magnetics announced on May 23, 2012 that it had entered into a Letter of Intent under which iTech Medical (OTC:IMSU) (FWB:0IM) would acquire 100% of BMMI. BIOflex Medical Magnetics holds the exclusive worldwide rights to the patented magnetic therapy product line, developed specifically for human medical use.
Related Stories:
"100 Million American Have Chronic Pain"- By Salynn Boyles, WebMD Health News, 06-29-11
New Study Shows That Pain Costs Hundreds of Billions of Dollars a Year in U.S.
"Cushy April Boosts Tempur-Pedic, Select Comfort" - By Kevin Harlin, Investor's Business Daily, 5-25-12
The high-end, non-spring mattress maker Tempur-Pedic (TPX) was up almost 6.2% to 50 midday. The adjustable-firmness mattress maker Select Comfort (SCSS) surged 6.3% to 28.25.
"Mattress maker shares up on strong sales" – the Associated Press, 5-26-12
KeyBanc Markets analyst Bradley Thomas, says "We continue to view the sector positively, despite increased concerns regarding competitive pressures."
About BIOFlex Medical Magnetics
BIOFlex Medical Magnetics is engaged in the sale of the patented BIOflex magnetic therapy product line. BIOflex is the original magnet manufactured specifically and exclusively for human medical use. BIOflex is an accepted form of therapy for use on sports injuries and chronic pain conditions including tendonitis, wrist and elbow pain, sprains and strains and chronic lower back pain. BIOflex Concentric Circle Magnets have been clinically tested at a number of prestigious institutions including the University of Kentucky, University of Tennessee and the Baylor College of Medicine.
For further information, visit the BIOflex Medical Magnetic Systems website: www.bioflexmagnets.com
About iTech Medical - (OTC:IMSU) (FWB:0IM)
iTech Medical is engaged in the research and commercial development of healthcare information systems and technologies. To date, the Company has focused on developing a proprietary platform called Muscle Pattern Recognition (MPR), a unique clinical and rehabilitation tool for the analysis of muscle function.
For more information go to the iTech Medical website: www.iTechMedical.com
Forward-Looking and Cautionary Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that reflect management's current views and estimates regarding future market conditions, company performance and financial results, business prospects, new strategies, the competitive environment and other events. You can identify these statements by the fact that they use words such as "anticipate," "believe," "estimate," "expect," "intend," "project," "plan," "outlook," and other words and terms of similar meaning.
These statements involve a number of risks and uncertainties that could cause actual results to materially differ from the potential results discussed in the forward-looking statements. Among the factors that could cause actual results and outcomes to differ materially from those contained in such forward-looking statements are the following: general economic conditions, acquisitions and development of new businesses, divestitures, product availability, sales volumes, pricing actions and promotional activities of our competitors, profit margins, weather, changes in law or regulations, foreign currency fluctuation, availability of suitable real estate locations, our ability to react to a disaster recovery situation, and the impact of labor markets and new product introductions on our overall profitability.
iTech Medical cautions that the foregoing list of important factors is not complete and assumes no obligation to update any forward-looking statements that it may make. All such forward-looking statements are current only as of the date on which such statements were made. iTech Medical, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.